Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
Janina Auth, MD (she/her/hers)
University Hospital Erlangen, Medicine 3
Erlangen, Germany
Disclosure information not submitted.
Christopher Denton, MD, PhD
University College London, UK
Northwood, United Kingdom
Disclosure(s): AbbVie: Consultant (Ongoing); Acceleron: Consultant (Ongoing); Arxx Therapeutics: Grant/Research Support (Ongoing); Bayer: Consultant (Ongoing); Boehringer-Ingelheim: Consultant (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Corbus: Consultant (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); CSL Behring: Consultant (Ongoing), Grant/Research Support (Ongoing); GlaxoSmithKline: Consultant (Ongoing), Grant/Research Support (Ongoing); Horizon Therapeutics: Consultant (Ongoing); Inventiva: Consultant (Ongoing), Grant/Research Support (Ongoing); Janssen: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Roche: Consultant (Ongoing); Sanofi: Consultant (Ongoing); Servier: Grant/Research Support (Ongoing)
Oliver Distler, MD
Department of Rheumatology, University Hospital Zurich, University of Zurich, Switzerland
Zurich, Switzerland
Disclosure(s): 4P Pharma: Consultant (Ongoing); AbbVie/Abbott: Advisor or Review Panel Member (Ongoing), Consultant (Ongoing); Acceleron: Consultant (Ongoing); Alcimed: Consultant (Ongoing); Altavant: Consultant (Ongoing); Amgen: Advisor or Review Panel Member (Ongoing); AnaMar: Consultant (Ongoing); Arxx: Consultant (Ongoing); AstraZeneca: Consultant (Ongoing); Blade: Consultant (Ongoing); Boehringer-Ingelheim: Advisor or Review Panel Member (Ongoing), Consultant (Ongoing); Corbus: Consultant (Ongoing); CSL Behring: Consultant (Ongoing); Galapagos: Consultant (Ongoing); Galderma: Consultant (Ongoing); Glenmark: Consultant (Ongoing); Gossamer: Consultant (Ongoing); Kymera: Consultant (Ongoing); Lupin: Consultant (Ongoing); Medscape: Consultant (Ongoing); Merck/MSD: Consultant (Ongoing); Miltenyi Biotec: Consultant (Ongoing); Mitsubishi Tanabe: Grant/Research Support (Ongoing); Novartis: Advisor or Review Panel Member (Ongoing), Consultant (Ongoing); Prometheus: Consultant (Ongoing); Redxpharma: Consultant (Ongoing); Roivant: Consultant (Ongoing); Topadur: Consultant (Ongoing)
Anna-Maria Hoffmann-Vold, MD, PhD
Oslo University Hospital
Oslo, Norway
Disclosure information not submitted.
Shefali Sharma, Sr, MD, MBBS (she/her/hers)
Government
Chandigarh, Chandigarh, India
Disclosure information not submitted.
Qingran Yan, MD, PhD (she/her/hers)
Department of Rheumatology, University Hospital Zurich
Zurich, Swaziland
Disclosure information not submitted.
Abstract oral session.
Non-CME
Presenting Author: Christopher Denton, MD, PhD – University College London, UK
Presenting Author: Oliver Distler, MD – Department of Rheumatology, University Hospital Zurich, University of Zurich, Switzerland
Presenting Author: Shefali Sharma, Sr, MD, MBBS (she/her/hers) – Government
Presenting Author: Qingran Yan, MD, PhD (she/her/hers) – Department of Rheumatology, University Hospital Zurich
Presenting Author: Anna-Maria Hoffmann-Vold, MD, PhD – Oslo University Hospital
Presenting Author: Janina Auth, MD (she/her/hers) – University Hospital Erlangen, Medicine 3